| Literature DB >> 35722524 |
Daiquan Gao1, Xiaojuan Zhang2, Yunzhou Zhang1, Rujiang Zhang3, Yuanyuan Qiao4.
Abstract
Aim: The aim of this study was to explore factors related to neurological deterioration (ND) after spontaneous intracerebral hemorrhage (sICH) and establish a prediction model based on random forest analysis in evaluating the risk of ND.Entities:
Keywords: factors; neurological deterioration; prediction model; random forest model; spontaneous intracerebral hemorrhage
Year: 2022 PMID: 35722524 PMCID: PMC9198834 DOI: 10.3389/fsurg.2022.886856
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Differential analysis of baseline information.
| Variables | Total ( | Group | Statistics |
| |
|---|---|---|---|---|---|
| Non-ND group ( | ND group ( | ||||
| Gender, | 0.611 | ||||
| Male | 268 (65.21) | 149 (63.95) | 119 (66.85) | ||
| Female | 143 (34.79) | 84 (36.05) | 59 (33.15) | ||
| Age (years), Mean ± SD | 59.43 ± 12.60 | 58.80 ± 12.87 | 60.25 ± 12.23 | 0.247 | |
| BMI (kg/m2), M (Q1, Q3) | 25.04 (22.56, 27.43) | 25.25 (22.53, 27.77) | 24.80 (22.59, 26.54) | 0.093 | |
| Time of onset to ED (h), M (Q1, Q3) | 13.00 (3.00, 48.00) | 24.00 (4.00, 48.00) | 8.00 (2.00, 24.00) | <0.001 | |
| SBP on admission (mmHg), M (Q1, Q3) | 162.00 (142.50, 183.00) | 160.00 (140.00, 180.00) | 166.50 (149.25, 187.00) | 0.028 | |
| DBP on admission (mmHg), M (Q1, Q3) | 91.00 (80.00, 104.50) | 90.00 (80.00, 104.00) | 91.50 (80.00, 105.00) | 0.425 | |
| Body temperature (°C), Mean ± SD | 36.68 ± 0.60 | 36.61 ± 0.45 | 36.76 ± 0.75 | 0.021 | |
| Baseline hematoma volume (ml), M (Q1, Q3) | 20.00 (10.00, 35.00) | 18.00 (10.00, 30.00) | 20.50 (10.00, 50.00) | 0.010 | |
| Hypertension, | 273 (66.42) | 149 (63.95) | 124 (69.66) | 0.267 | |
| Smoking history, | 145 (35.28) | 81 (34.76) | 64 (35.96) | 0.884 | |
| Drinking history, | 151 (36.74) | 84 (36.05) | 67 (37.64) | 0.820 | |
| Other medical history, | 108 (26.28) | 63 (27.04) | 45 (25.28) | 0.773 | |
| Serum sodium (mmol/l), M (Q1, Q3) | 140.00 (137.75, 142.35) | 139.80 (137.00, 142.00) | 140.30 (138.00, 143.00) | 0.008 | |
| Serum calcium (mmol/l), M (Q1, Q3) | 2.18 (2.06, 2.25) | 2.21 (2.10, 2.27) | 2.13 (2.01, 2.21) | <0.001 | |
| Hemoglobin (g/l), M (Q1, Q3) | 138.00 (124.00, 150.00) | 138.00 (126.00, 150.00) | 137.50 (120.25, 149.75) | 0.315 | |
| WBC count (109/L), M (Q1, Q3) | 8.80 (7.12, 12.00) | 8.60 (6.77, 11.30) | 8.90 (7.54, 12.37) | 0.030 | |
| PLT count (109/L), M (Q1, Q3) | 212.00 (176.50, 249.00) | 220.00 (186.00, 252.00) | 206.00 (170.25, 246.00) | 0.045 | |
| Activated partial thromboplastin time (s), M (Q1, Q3) | 31.60 (27.90, 35.60) | 32.10 (28.40, 36.30) | 30.95 (27.40, 35.45) | 0.108 | |
| INR (s), M (Q1, Q3) | 1.02 (0.97, 1.09) | 1.01 (0.96, 1.08) | 1.04 (0.97, 1.11) | 0.017 | |
| Fibrous protein (g/l), M (Q1, Q3) | 3.30 (2.70, 4.11) | 3.40 (2.70, 4.13) | 3.20 (2.64, 3.91) | 0.171 | |
| Blood glucose (mmol/l), M (Q1, Q3) | 6.40 (5.44, 8.02) | 6.20 (5.40, 7.50) | 6.60 (5.56, 8.68) | 0.017 | |
| Serum creatinine (umol/l), M (Q1, Q3) | 60.40 (51.65, 73.40) | 59.80 (51.30, 72.00) | 62.20 (52.47, 74.00) | 0.145 | |
| Troponin, ug/l, M (Q1, Q3) | 0.12 (0.01, 1.05) | 0.67 (0.01, 1.08) | 0.08 (0.01, 1.01) | 0.962 | |
| TCHO (mg/dl), M (Q1, Q3) | 4.13 (3.50, 4.84) | 4.23 (3.56, 4.95) | 4.09 (3.42, 4.71) | 0.064 | |
| LDL-C (mg/dl), M (Q1, Q3) | 2.51 (1.92, 3.12) | 2.60 (2.00, 3.17) | 2.46 (1.81, 3.01) | 0.057 | |
| HDL-C (mg/dl), M (Q1, Q3) | 1.15 (0.96, 1.36) | 1.18 (0.97, 1.38) | 1.12 (0.95, 1.32) | 0.180 | |
| Triglyceride (mg/dl), M (Q1, Q3) | 1.16 (0.84, 1.61) | 1.19 (0.87, 1.63) | 1.13 (0.80, 1.61) | 0.266 | |
| Bleeding part, | 0.349 | ||||
| Others | 90 (21.90) | 56 (24.03) | 34 (19.10) | ||
| Basal ganglia | 199 (48.42) | 111 (47.64) | 88 (49.44) | ||
| Brain stem | 25 (6.08) | 10 (4.29) | 15 (8.43) | ||
| Brain lobe | 74 (18.00) | 44 (18.88) | 30 (16.85) | ||
| Cerebellum | 23 (5.60) | 12 (5.15) | 11 (6.18) | ||
| IVH, | 132 (32.12) | 61 (26.18) | 71 (39.89) | 0.004 | |
| IVH expansion, | 27 (6.57) | 17 (7.30) | 10 (5.62) | 0.632 | |
| Subarachnoid expansion, | 9 (2.19) | 6 (2.58) | 3 (1.69) | Fisher | 0.738 |
| DBP change in 24 h (mmHg), M (Q1, Q3) | 13.00 (5.00, 27.00) | 13.00 (4.00, 25.00) | 13.00 (5.00, 28.00) | 0.321 | |
| SBP change in 24 h (mmHg), M (Q1, Q3) | 19.00 (3.00, 43.50) | 16.00 (2.00, 41.00) | 20.50 (5.00, 50.75) | 0.098 | |
| Hematoma volume change in 24 h (ml), M (Q1, Q3) | 0.00 (0.00, 15.00) | 0.00 (0.00, 10.00) | 3.00 (0.00, 20.00) | 0.008 | |
| Blend sign, | 51 (12.41) | 25 (10.73) | 26 (14.61) | 0.303 | |
| Spot sign, | 90 (21.90) | 48 (20.60) | 42 (23.60) | 0.544 | |
| Leukodystrophy, | 105 (25.55) | 60 (25.75) | 45 (25.28) | 1.000 | |
| Lacuna cerebri, | 139 (33.82) | 79 (33.91) | 60 (33.71) | 1.000 | |
| Brain atrophy, | 59 (14.36) | 24 (10.30) | 35 (19.66) | 0.011 | |
ND, neurological deterioration; BMI, body mass index; ED, Emergency Department; SBP, systolic blood pressure; DBP, diastolic blood pressure; IVH, intraventricular hemorrhage; WBC, white blood cell; PLT, platelet; INR, international normalized ratio; TCHO, total cholesterol; LDL-C, low-density lipoprotein cholesterin; HDL-C, high-density lipoprotein cholesterol.
Figure 1The factors related to the neurological deterioration in patients with acute intracerebral hemorrhage by multivariate logistic analysis.
Figure 2The factors related to the neurological deterioration in patients with acute intracerebral hemorrhage by multivariate logistic analysis (before interpolation).
Differences between the training set and testing set.
| Variables | Total ( | Training set ( | Testing set ( | Statistics |
|
|---|---|---|---|---|---|
| Onset to ED Arrival (h), M (Q1, Q3) | 13.00 (3.00, 48.00) | 13.00 (3.00, 48.00) | 15.50 (3.00, 48.00) | 0.776 | |
| SBP on admission (mmHg), M (Q1, Q3) | 162.00 (142.50, 183.00) | 160.00 (141.50, 183.00) | 165.00 (145.75, 180.75) | 0.537 | |
| Baseline hematoma volume (ml), M (Q1, Q3) | 20.00 (10.00, 35.00) | 20.00 (10.00, 30.00) | 20.00 (12.00, 40.00) | 0.203 | |
| Serum sodium (mmol/l), M (Q1, Q3) | 140.00 (137.75, 142.35) | 140.00 (137.70, 142.05) | 140.00 (137.98, 142.85) | 0.950 | |
| Serum calcium (mmol/l), M (Q1, Q3) | 2.18 (2.06, 2.25) | 2.19 (2.07, 2.25) | 2.17 (2.05, 2.25) | 0.498 | |
| IVH expansion, | 27 (6.57) | 16 (5.57) | 11 (8.87) | 0.307 | |
| Brain atrophy, | 59 (14.36) | 41 (14.29) | 18 (14.52) | 1.000 | |
| SBP Change in 24 h (mmHg), M (Q1, Q3) | 19.00 (3.00, 43.50) | 19.00 (2.00, 43.00) | 20.00 (5.00, 45.25) | 0.439 | |
| Age (years), Mean ± SD | 59.43 ± 12.60 | 59.89 ± 13.88 | 59.23 ± 12.03 | 0.647 | |
| Gender (female), | 143 (34.79) | 45 (36.29) | 98 (34.15) | 0.760 |
ED, Emergency Department; SBP, systolic blood pressure; IVH, intraventricular hemorrhage.
Figure 3The feature importance diagram of the random forest model.
Figure 4Individual histograms.
Prediction effect of the random forest model.
| Variables | AUC (95% CI) | Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) |
|---|---|---|---|---|---|
| Training set | 0.795 (0.793–0.797) | 0.737 (0.686–0.788) | 0.688 (0.634–0.741) | 0.787 (0.739–0.834) | 0.626 (0.570–0.682) |
| Testing set | 0.713 (0.710–0.716) | 0.697 (0.617–0.778) | 0.667 (0.584–0.750) | 0.768 (0.694–0.842) | 0.613 (0.495–0.669) |
AUC, area under the curve; CI, confidence interval; PPV, positive predictive value; NPV, negative predictive value.